KCM
EW icon

Key Capital Management’s Edwards Lifesciences EW Stock Holding History

Key Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81K Hold
20
– – ﹤0.01% 598
2026
Q1 		$1.6K Hold
20
– – ﹤0.01% 566
2025
Q4 		$1.71K Buy
+20
New +$1.64K ﹤0.01% 401

Other funds holding EW

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Key Capital Management's EW Position: Q2 2026 in Review

Key Capital Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 20 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #598.

Key Capital Management first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 719 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Key Capital Management held 20 shares of Edwards Lifesciences worth $1.81K as of Q2 2026.
  • Key Capital Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Key Capital Management's portfolio in Q2 2026, its #598 holding.
  • Key Capital Management first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 719 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Key Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.